Literature DB >> 9730565

Plasma concentration of brain natriuretic peptide as an indicator of cardiac ventricular function in patients on hemodialysis.

K Nitta1, A Kawashima, W Yumura, M Naruse, T Oba, T Kabaya, H Nihei.   

Abstract

The plasma concentration of human brain natriuretic peptide (BNP) was measured by immunoradiometric assay in patients on maintenance hemodialysis (HD) to assess the possible relationship between the plasma levels of this peptide and cardiac ventricular function, as judged by M-mode echocardiography. The plasma BNP levels in the pre-HD state were significantly higher (688.5 +/- 154.5 pg/ml) than those of healthy subjects (<40 pg/ml). In addition, the plasma BNP levels were slightly decreased during HD (post-HD, 617.3 +/- 157.1 pg/ml). There was no correlation between the plasma levels of BNP and body weight changes during HD. The mean plasma BNP level was significantly higher in the group of patients with a low left ventricular ejection fraction (EF < 60%) than in the group with a normal EF. In the patients as a whole, there was an inverse correlation between plasma BNP levels and EF. Moreover, a positive correlation was found between plasma BNP levels and left ventricular mass index (r = 0.57, p < 0.05). These results suggest that plasma BNP levels increase in response to chronic stimulation in accordance with increased cardiac load, and that they may be a possible indicator of reduced ventricular function in HD patients.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9730565     DOI: 10.1159/000013385

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  11 in total

1.  Cholecalciferol supplementation in hemodialysis patients: effects on mineral metabolism, inflammation, and cardiac dimension parameters.

Authors:  Patrícia João Matias; Cristina Jorge; Carina Ferreira; Marília Borges; Inês Aires; Tiago Amaral; Célia Gil; José Cortez; Aníbal Ferreira
Journal:  Clin J Am Soc Nephrol       Date:  2010-03-04       Impact factor: 8.237

2.  Serum levels of N-terminal pro-B-type natriuretic peptide are associated with allograft function in recipients of renal transplants.

Authors:  Gerd Bodlaj; Rainer Hubmann; Karim Saleh; Georg Biesenbach; Erich Pohanka; Tatjana Stojakovic; Jörg Berg
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

3.  Plasma levels of brain natriuretic peptides and cardiac troponin in hemodialysis patients.

Authors:  Halima Resić; Selma Ajanović; Nihad Kukavica; Fahrudin Masnić; Aida Corić
Journal:  Bosn J Basic Med Sci       Date:  2009-05       Impact factor: 3.363

4.  Predictive value of brain natriuretic peptides in patients on peritoneal dialysis: results from the ADEMEX trial.

Authors:  Ramon Paniagua; Dante Amato; Salim Mujais; Edward Vonesh; Alfonso Ramos; Ricardo Correa-Rotter; Walter H Horl
Journal:  Clin J Am Soc Nephrol       Date:  2008-01-16       Impact factor: 8.237

5.  The role of natriuretic peptides in volume assessment and mortality prediction in Haemodialysis patients.

Authors:  Murugan Sivalingam; Enric Vilar; Suresh Mathavakkannan; Ken Farrington
Journal:  BMC Nephrol       Date:  2015-12-29       Impact factor: 2.388

6.  Association between Low Serum Bicarbonate Concentrations and Cardiovascular Disease in Patients in the End-Stage of Renal Disease.

Authors:  Vaia D Raikou; Despina Kyriaki
Journal:  Diseases       Date:  2016-11-15

7.  Association of cardiac and renal function with extreme N-terminal fragment pro-B-type natriuretic peptide levels in elderly patients.

Authors:  Hua Cui; Guoliang Huo; Lin Liu; Li Fan; Ping Ye; Jian Cao; Yongyi Bai; Fan Wang; Yixin Hu
Journal:  BMC Cardiovasc Disord       Date:  2012-07-26       Impact factor: 2.298

8.  Relationship between serum brain natriuretic peptide and heart function in patients with chronic kidney disease.

Authors:  Jae Won Yang; Min Soo Kim; Jae Seok Kim; Jong Myoung Yoo; Seung Tae Han; Bi Ro Kim; Yun Deok Kim; Jeong Wook Choi; Seung Ok Choi; Byoung Geun Han
Journal:  Korean J Intern Med       Date:  2008-12       Impact factor: 2.884

9.  Mortality and Low Serum Bicarbonate Level in Patients on Hemodiafiltration versus Peritoneal Dialysis.

Authors:  V D Raikou; D Kyriaki
Journal:  Indian J Nephrol       Date:  2018 Mar-Apr

10.  Effects of tolvaptan on renal function in chronic kidney disease patients with volume overload.

Authors:  Shunji Suzuki; Norio Hanafusa; Kenji Kubota; Ken Tsuchiya; Kosaku Nitta
Journal:  Int J Nephrol Renovasc Dis       Date:  2018-08-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.